Skip to content
DilutionScan
AXE COMPUTE INC. logo
AGPU$7.56-0.72%

Axe Compute Inc.

Sector: Finance ServicesIndustry: Software - InfrastructureCountry: USExchange: Nasdaq

Mkt Cap$87.57M
Float & O/S
Inst Own

DilutionScan read 29 of AXE COMPUTE INC.'s SEC filings and found 7 warrant series, 1 convertible, 1 ATM program, 1 equity line, 5 shelf registrations, 1 S-1 registration and 2 completed offerings on file for AGPU. The latest dilution event on file is a registration statement on Jul 27, 2026. Analysis updated Oct 5, 2026.

Signal8 Summary

AGPU

Speculative pivot with severe dilution overhang

Snapshot

Axe Compute just pivoted from a cancer-diagnostics company into an AI GPU-compute business. FY2025 revenue (still mostly the old business) was only $125K with a $233.1M net loss, and the company burned $42.5M in free cash flow.

What's Happening Right Now

  • : On Oct 5, 2026, Axe Compute took full ownership of its Georgia AI server cluster from Duos Technologies, paying off $87.8M in debt with no new equity and extending the customer contract to 2031.
  • : Since its August earnings call, Axe Compute has received over $184M in customer prepayments and signed $266M more in AI infrastructure contracts, pushing total signed value past $3.45 billion.
  • : On Sep 15, 2026, Axe Compute sold its legacy Helomics cancer-diagnostics lab to DataMEDS AI, completing its full transition from the old Predictive Oncology business into a pure-play GPU compute provider.
  • : On Aug 17, 2026 (announced Sep 10), Axe Compute agreed with Duos Technologies to add 55 MW of new AI data center capacity worth over $500M, with Axe taking a planned 49% equity stake in the project entities.
  • : Q2 2026 revenue hit $3.2M, up roughly 90x sequentially as its first full quarter of compute revenue, while net loss was $17.2M, mostly from a non-cash $13.1M loss on digital-asset holdings; signed contract value topped $3 billion.
  • : Registered $1.00B of securities for sale on Form S-3.
  • : Sold $10.30M net through its at-the-market program, as stated for Apr 1, 2026 to Jun 30, 2026.
  • : Sold $12.70M of stock / 1.20M shares through its at-the-market program, as stated for May 16, 2025 to May 15, 2026.

DilutionScan ProEvery instrument in full · $59/mo